Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,317 | -6,604 | -1,100 | -3,455 | -3,619 |
| Depreciation Amortization | 404 | 1,465 | 1,078 | 706 | 346 |
| Income taxes - deferred | 71 | 340 | 177 | 118 | -113 |
| Accounts receivable | 6,408 | -5,890 | -11,768 | -6,919 | -2,275 |
| Other Working Capital | 2,538 | -10,119 | -15,875 | -8,739 | -1,840 |
| Other Operating Activity | -5,713 | 8,815 | 13,465 | 7,998 | 2,443 |
| Operating Cash Flow | $22,025 | $-11,993 | $-14,023 | $-10,291 | $-5,058 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,991 | 4,298 | N/A | N/A | N/A |
| PPE Investments | -761 | -1,638 | -1,235 | -737 | -306 |
| Purchase Of Investment | N/A | -5,000 | N/A | N/A | N/A |
| Other Investing Activity | -7 | -26 | -19 | -13 | -6 |
| Investing Cash Flow | $4,223 | $-2,366 | $-1,254 | $-750 | $-312 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 150 | 9,326 | 9,180 | 9,180 | 5,076 |
| Financing Cash Flow | $150 | $9,326 | $9,180 | $9,180 | $5,076 |
| Exchange Rate Effect | -77 | -47 | -16 | -4 | -8 |
| Beginning Cash Position | 14,680 | 19,760 | 19,760 | 19,760 | 19,760 |
| End Cash Position | 41,001 | 14,680 | 13,647 | 17,895 | 19,458 |
| Net Cash Flow | $26,321 | $-5,080 | $-6,113 | $-1,865 | $-302 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,025 | -11,993 | -14,023 | -10,291 | -5,058 |
| Capital Expenditure | -761 | -1,638 | -1,235 | -737 | -306 |
| Free Cash Flow | 21,264 | -13,631 | -15,258 | -11,028 | -5,364 |